Relapsing MS patients fared better after switch to Kesimpta | Multiple Sclerosis News Today
People with relapsing MS who experienced disease activity while on oral therapies had less disease activity after switching to Kesimpta.
Stay updated with breaking news from Multiple Sclerosis News. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
People with relapsing MS who experienced disease activity while on oral therapies had less disease activity after switching to Kesimpta.
Get Multiple Sclerosis latest news, Article video and Photos on Multiple Sclerosis Explore latest health updates, news, information from TheHealthSite.com
More than 80% of relapsing MS patients who took Kesimpta continuously for five years in a trial did not have any worsening of disability.
The podcast, which coincides with MS awareness month, tells the story of Tyler Campbell, a onetime football player turned patient advocate.
A new documentary, "MS in Black and African Americans," explores the experiences of Black patients in the U.S. living with multiple sclerosis.